Literature DB >> 1741053

AIDS vaccine developments.

R Le Grand, B Vaslin, G Vogt, P Roques, M Humbert, D Dormont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1741053     DOI： 10.1038/355684a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

Authors:  J A Kovacs; M B Vasudevachari; M Easter; R T Davey; J Falloon; M A Polis; J A Metcalf; N Salzman; M Baseler; G E Smith
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

2.  Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques.

Authors:  Y Wang; L Tao; E Mitchell; W M Bogers; C Doyle; C A Bravery; L A Bergmeier; C G Kelly; J L Heeney; T Lehner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines.

Authors:  Z R Israel; P F Edmonson; D H Maul; S P O'Neil; S P Mossman; C Thiriart; L Fabry; O Van Opstal; C Bruck; F Bex
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

4.  Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.

Authors:  F Baldinotti; D Matteucci; P Mazzetti; C Giannelli; P Bandecchi; F Tozzini; M Bendinelli
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry.

Authors:  A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

6.  Transcomplementation of simian immunodeficiency virus Rev with human T-cell leukemia virus type I Rex.

Authors:  K J Krohn; K Hakkarainen; E Aavik; S Dewhurst; R Sadaie; J I Mullins
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  Immunogenicity of a viral model vaccine after different inactivation procedures.

Authors:  M F Bachmann; C Bast; H Hengartner; R M Zinkernagel
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

8.  Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses.

Authors:  M F Bachmann; T M Kündig; C P Kalberer; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Sulfation of the human immunodeficiency virus envelope glycoprotein.

Authors:  H B Bernstein; R W Compans
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Antibodies to human and non-human primate cellular and culture medium components in macaques vaccinated with the simian immunodeficiency virus.

Authors:  L A Bergmeier; J Walker; L Tao; M Cranage; T Lehner
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.